Abstract:Abstract Accumulating evidence indicates that intracellular reactive oxygen species (ROS) production is highly involved in bone homeostasis by intervening osteoclast or osteoblast differentiation. Interestingly, ROS that are known as oxidizing agents exert dose-dependent biphasic properties in bone remodeling, including preventing osteoblast activity but accelerating osteoclast resorption. ROS mainly composed of superoxide anion radical, hydroxyl radical, nitric oxide, and two-electron reduction product hydrogen peroxide, which are important components to regulate bone cell metabolism and function in mammal skeleton. These free radicals can be partly produced in bone and boosted in an inflammation state. Although numerous researches have emphasized the impacts of ROS on bone cell biology and verified the mechanism of ROS signaling cascades, the recapitulatory commentary is necessary. In this review article, we particularly focus on the regulation of the intracellular ROS and its potential mechanism impacting on cell-signaling transduction in osteoclast and osteoblast differentiation for preferable understanding the pathogenesis and searching for novel therapeutic protocols for human bone diseases.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore the role of reactive oxygen species (ROS) signal cascades in osteocyte metabolism, especially their influence on the differentiation of osteoclasts and osteoblasts. As important intracellular signaling molecules, ROS play a crucial role in maintaining bone homeostasis. However, excessive production of ROS can lead to oxidative stress, which in turn affects the functions of osteocytes, such as inhibiting osteoblast activity but accelerating osteoclast resorption, resulting in bone loss and dysfunction. Therefore, the paper aims to deeply understand the regulatory mechanisms of ROS in osteocyte signal transduction, in order to provide a deeper understanding of the pathological mechanisms of human bone diseases and explore new treatment strategies. Specifically, the paper focuses on the following aspects: 1. **Generation and Regulation of ROS**: The paper describes in detail the main components of ROS (such as superoxide anion radical \( \cdot O_2^{-} \), hydroxyl radical \( \cdot OH \), nitric oxide \( NO \) and hydrogen peroxide \( H_2O_2 \)), as well as the intracellular generation pathways and regulatory mechanisms of these radicals. 2. **Role of ROS in Osteoclast Differentiation**: The paper discusses how ROS promotes the differentiation and maturation of osteoclasts by activating signaling pathways such as MAPK, PI3K and NF - κB, and the role of ROS in the inflammatory response. 3. **Role of ROS in Osteoblast Differentiation**: The paper explores the effects of ROS on osteoblast proliferation, apoptosis and adhesion, especially the negative effects of ROS on osteoblast activity under pathological conditions. 4. **Biphasic Effects of ROS**: The paper emphasizes the dose - dependent biphasic effects of ROS, that is, a moderate level of ROS may promote osteocyte function, while excessive ROS will lead to cell damage and dysfunction. 5. **Application of ROS Scavengers**: The paper also discusses the potential applications of ROS scavengers (such as antioxidant enzymes and cytoprotective molecules) in the prevention and treatment of bone diseases, especially by activating the Nrf2 signaling pathway to reduce the harmful effects of ROS. In conclusion, by reviewing the complex role of ROS in osteocyte metabolism, this paper provides a new perspective for understanding the pathological mechanisms of bone diseases and a theoretical basis for developing new treatment strategies.

ROS signaling cascades: dual regulations for osteoclast and osteoblast